Article Versions Notes

Keizman D, Frenkel M, Peer A, Kushnir I, Rosenbaum E, Sarid D, Leibovitch I, Mano R, Yossepowitch O, Margel D, et al. Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study. Nutrients. 2021; 13(12):4295. https://doi.org/10.3390/nu13124295

Keizman, Daniel, Moshe Frenkel, Avivit Peer, Igal Kushnir, Eli Rosenbaum, David Sarid, Ilan Leibovitch, Roy Mano, Ofer Yossepowitch, David Margel, and et al. 2021. "Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study" Nutrients 13, no. 12: 4295. https://doi.org/10.3390/nu13124295

Keizman, D., Frenkel, M., Peer, A., Kushnir, I., Rosenbaum, E., Sarid, D., Leibovitch, I., Mano, R., Yossepowitch, O., Margel, D., Wolf, I., Geva, R., Dresler, H., Rouvinov, K., Rapoport, N., & Eliaz, I. (2021). Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study. Nutrients, 13(12), 4295. https://doi.org/10.3390/nu13124295